{"entity":{"id":"nct06010342","kind":"trial","name":"A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients","aka":[],"tldr":"A phase 2 trial of TL118 Capsule in advanced solid tumours, run by Teligene US, now recruiting.","summary":"A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients is a phase 2 interventional study registered as NCT06010342 by Teligene US, with 60 participants planned, started 2023-03-16 and due to reach its primary completion in 2027-12. Interventions recorded: TL118 Capsule.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06010342","url":"https://clinicaltrials.gov/study/NCT06010342"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06010342","phase":"2","setting":"A Phase 2 Study of TL118 for the Treatment of Patients With Solid Tumors Harboring NTRK Gene Fusions","sponsor":"Teligene US","enrolled":60,"outcomes":[]},"route":"/trials/nct06010342/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}]}}